Personal information

No personal information available

Activities

Collapse all

Employment (4)

Texas Children's Hospital: Houston, TX, US

2019-07-08 to present | Assistant Professor (Department of Pediatrics, Center for Cell and Gene Therapy)
Employment
Source: Self-asserted source
Brian Friend

UCSF Benioff Children's Hospital: San Francisco, CA, US

2018-07-01 to 2019-06-30 | BMT Fellow (Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation)
Employment
Source: Self-asserted source
Brian Friend

UCLA Health System: CA, CA, US

2015-07-01 to 2018-06-30 | Fellow Physician (Pediatrics, Hematology-Oncology)
Employment
Source: Self-asserted source
Brian Friend

UCLA Health System: CA, CA, US

2012-06-24 to 2015-06-30 | Resident Physician (Pediatrics)
Employment
Source: Self-asserted source
Brian Friend

Education and qualifications (2)

University of Southern California: Los Angeles, CA, US

2008-08-20 to 2012-05-10 | Bachelor of Arts
Education
Source: Self-asserted source
Brian Friend

University of Nebraska College of Medicine: Omaha, NE, US

2008-08-20 to 2012-05-05 | Doctor of Medicine
Education
Source: Self-asserted source
Brian Friend

Works (13)

“Just let me go”; When suicidal ideation and goals of care collide in adolescent cancer at the end of life

Pediatric Blood & Cancer
2024-06 | Journal article
DOI: 10.1002/pbc.30893
Contributors: Bryony Lucas; Brian Friend; Jill Ann Jarrell; Rachel Kentor
Source: check_circle
Crossref

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

Pediatric Hematology and Oncology
2024-05-18 | Journal article
DOI: 10.1080/08880018.2023.2296933
Contributors: Luisanna M. Sánchez; Anil George; Brian D. Friend; Saleh Bhar; Ghadir Sasa; Erin E. Doherty; John Craddock; David Steffin; Baheyeldin Salem; Khaled Yassine et al.
Source: check_circle
Crossref

Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy
2023-02 | Journal article
DOI: 10.1016/j.jtct.2022.11.019
Contributors: Brian D. Friend; Larisa Broglie; Brent R. Logan; Saurabh Chhabra; Caitrin Bupp; Gary Schiller; Amer Beitinjaneh; Miguel Angel Diaz Perez; Gregory M.T. Guilcher; Hasan Hashem et al.
Source: check_circle
Crossref

Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases

Transplantation and Cellular Therapy
2023-02 | Journal article
DOI: 10.1016/j.jtct.2022.11.020
Contributors: Larisa Broglie; Brian D. Friend; Saurabh Chhabra; Brent R. Logan; Caitrin Bupp; Gary Schiller; Bipin N. Savani; Edward Stadtmauer; Allistair A. Abraham; Mahmoud Aljurf et al.
Source: check_circle
Crossref

Treatment intensity in AML: a double-edged sword

Blood
2023-01-05 | Journal article
DOI: 10.1182/blood.2022018183
Contributors: Brian D. Friend
Source: check_circle
Crossref

Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians

Leukemia & Lymphoma
2022-08-24 | Journal article
DOI: 10.1080/10428194.2022.2076848
Contributors: Larisa Broglie; Brian D. Friend; Saurabh Chhabra; Caitrin Bupp; Gary J. Schiller; Brent Logan; Marcelo C. Pasquini; Bipin Savani; Edward A. Stadtmauer; Monica S. Thakar et al.
Source: check_circle
Crossref

Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion

Pediatric Hematology and Oncology
2022-08-18 | Journal article
DOI: 10.1080/08880018.2022.2035028
Contributors: Lois M. Dodson; Kristen J. Kurtz; Andrea N. Marcogliese; Brian D. Friend; Alexandra M. Stevens; Kevin E. Fisher
Source: check_circle
Crossref

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation

Blood
2021-02-18 | Journal article
DOI: 10.1182/blood.2020009342
Contributors: Muna Qayed; Kwang Woo Ahn; Carrie L. Kitko; Mariam H. Johnson; Nirali N. Shah; Christopher Dvorak; Karin Mellgren; Brian D. Friend; Michael R. Verneris; Wing Leung et al.
Source: check_circle
Crossref

The impact of total body irradiation‐based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation

Pediatric Blood & Cancer
2020-02 | Journal article
DOI: 10.1002/pbc.28079
Contributors: Brian D. Friend; Mara Bailey‐Olson; Alexis Melton; Kristin A. Shimano; Sandhya Kharbanda; Christine Higham; Lena E. Winestone; James Huang; Elliot Stieglitz; Christopher C. Dvorak
Source: check_circle
Crossref

Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation

Pediatric Blood & Cancer
2019-12 | Journal article
DOI: 10.1002/pbc.27940
Contributors: Brian D. Friend; Kevin Tang; Daniela Markovic; David Elashoff; Theodore B. Moore; Gary J. Schiller
Source: check_circle
Crossref

Is polycystic kidney disease associated with malignancy in children?

Molecular Genetics & Genomic Medicine
2019-07 | Journal article
DOI: 10.1002/mgg3.725
Contributors: Brian D. Friend; Kami Wolfe Schneider; Timothy Garrington; Laurel Truscott; Julian A. Martinez‐Agosto; Robert S. Venick; Eileen Tsai Chambers; Patricia Weng; Douglas G. Farmer; Vivian Y. Chang et al.
Source: check_circle
Crossref

Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults

Blood Reviews
2018-03 | Journal article
DOI: 10.1016/j.blre.2017.09.005
Contributors: Brian D. Friend; Gary J. Schiller
Source: check_circle
Crossref

Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma

Pediatric Blood & Cancer
2017-12 | Journal article
DOI: 10.1002/pbc.26682
Contributors: Brian D. Friend; Robert S. Venick; Sue V. McDiarmid; Xiaoyan Zhou; Bita Naini; Hanlin Wang; Douglas G. Farmer; Ronald W. Busuttil; Noah Federman
Source: check_circle
Crossref
How many people are using ORCID?